1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Summary of primary HNSCC tumor sites evaluated

Primary SiteNo. of Patients
Untreated tumors (n = 22)
    Larynx7a
    Hypopharynx1
    Retromolar trigone, anterior tonsillar pillar3
    Oral cavity, other5
    Oropharynx, other3
    Sinuses, nose3
Recurrent or metastatic tumors (n = 8)
    HNSCC invading parotid (n = 2), parapharyngeal space metastasis, oral cavity (n = 2), base of tongue, cheek, neopharynx
  • a Three of 7 laryngeal tumors had pathologically proven thyroid cartilage invasion.